NutriBand (NTRB) Current Leases (2019 - 2026)

NutriBand's (NTRB) quarterly Current Leases came in at $32453.0 in Q1 2026, up 2.3% quarter-over-quarter from $31722.0 in Q4 2025.

NutriBand (NTRB) Current Leases (2019 - 2026) Analysis & Trends

NutriBand has disclosed Current Leases across 8 years of filings, most recently posting $32453.0 for Q1 2026.

  • Current Leases for Q1 2026 came in at $32453.0, changed N/A year-over-year; the trailing twelve-month figure through Jan 2026 was $32453.0 (changed N/A YoY), and the FY2026 annual result was $32453.0, changed N/A from the prior year.
  • Current Leases came in at $32453.0 for Q1 2026 at NutriBand, up from $31722.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $34276.0 in Q1 2024 to a low of $8864.0 in Q4 2024.
  • The 5-year median for Current Leases is $31149.0 (2023), against an average of $27814.6.
  • Across the five-year window, Current Leases slumped 73.54% in 2024 and soared 257.87% in 2025, its largest moves.
  • NutriBand's Current Leases stood at $30586.0 in 2022, then increased by 9.54% to $33505.0 in 2023, then plunged by 73.54% to $8864.0 in 2024, then jumped by 257.87% to $31722.0 in 2025, then grew by 2.3% to $32453.0 in 2026.
  • The last three Current Leases figures came in at $32453.0 (Q1 2026), $31722.0 (Q4 2025), and $31007.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 83,991.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 7.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 32,453.00

Historic Data

Download Data
DateValue
Jan 31, 2026 32,453.00
Oct 31, 2025 31,722.00
Jul 31, 2025 31,007.00
Apr 30, 2025 30,309.00
Oct 31, 2024 8,864.00
Jul 31, 2024 17,528.00
Apr 30, 2024 25,988.00
Jan 31, 2024 34,276.00
Oct 31, 2023 33,505.00
Jul 31, 2023 32,750.00
Apr 30, 2023 32,012.00
Jan 31, 2023 31,291.00
Oct 31, 2022 30,586.00
Jul 31, 2022 19,526.00
Apr 30, 2022 33,885.00
Jan 31, 2022 19,331.00
Oct 31, 2021 106,031.00
Jul 31, 2021 25,506.00
Apr 30, 2021 25,119.00
Jan 31, 2021 24,740.00